Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697980 · ClinicalTrials.gov registry record
Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 136
- Enrollment target
NCT03697980 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 136 participants.
The verdict
NCT03697980 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
Medtronic is sponsoring the Apogee study to further enhance scientific understanding of the implant procedure, optimized blood pressure management, and anticoagulation/ antiplatelet therapy in patients receiving a Medtronic HeartWare™ Ventricular Assist Device (HVAD™) for destination therapy. The Apogee study is conducted within Medtronic's Product Surveillance Platform.
Interventions
- DEVICE HeartWare Ventricular Assist Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2019-01-17 |
| Est. Completion | 2022-02-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03697980
The ClinicalTrials.gov registry entry for NCT03697980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HeartWare Ventricular Assist Device is the first listed.
NCT03697980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03697980 about?
NCT03697980 is a clinical study titled "Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform". Medtronic is sponsoring the Apogee study to further enhance scientific understanding of the implant procedure, optimized blood pressure management, and anticoagulation/ antiplatelet therapy in patients receiving a Medtronic HeartWare™ Ventricular Assist Device (HVAD™) for destination therapy. The A...
What is the current status of trial NCT03697980?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2019-01-17. Estimated completion is 2022-02-10.
What interventions are being tested in trial NCT03697980?
The interventions under investigation include: HeartWare Ventricular Assist Device (DEVICE).
Who is sponsoring clinical trial NCT03697980?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.